| Aspirin group (n = 11) | DAPT group (n = 17) | ||||
---|---|---|---|---|---|---|
Before ET | After ET | p | Before ET | After ET | p | |
PA, % | 72.9 (7.5)* | 80.9 (7.6)** | 0.005 | 43.0 (21.5)* | 50.1 (20.9)** | 0.010 |
CD62p, % | 8.1 (3.2) | 9.7 (5.0) | 0.178 | 6.6 (4.4) | 7.3 (3.0) | 0.375 |
CD62p(+ADP), % | 33.5 (17.0) | 34.5 (12.9) | 0.701 | 22.5 (14.4) | 25 (9.4) | 0.342 |
PAC-1, % | 0.46 (0.4) | 0.57 (0.41) | 0.29 | 0.36 (0.25) | 0.51 (0.34) | 0.067 |
PAC-1(+ADP), % | 5.62 (2.16) | 6.22 (2.88) | 0.181 | 4.4 (1.18) | 4.94 (1.7) | 0.179 |
Platelet count, × 109 | 210.9 (54.6) | 227.5 (58.1) | 0.001 | 217.5 (63.8) | 229.7 (63.7) | 0.001 |
MPV,fl | 10.6 (1.1) | 10.7 (0.9) | 0.645 | 11.0 (0.7) | 11.1 (0.8) | 0.201 |